Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Novavax Continues To Work With The U.S. FDA On Authorization Of 2024-2025 Formula Covid-19 Vaccine; Expect To Have Authorization For 2024-2025 Formula Covid-19 Vaccine In Time For Peak Vaccination Season

Author: Benzinga Newsdesk | August 22, 2024 02:04pm

- Reuters

Posted In: NVAX